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Abstract
Cell patches are widely used for healing injuries on the surfaces or interfaces of tissues such as
those of epidermis and myocardium. Here we report a novel type of porous scaffolds made of
poly(D,L-lactic-co-glycolic acid) for fabricating cell patches. The scaffolds have a single layer of
spherical pores arranged in a unique hexagonal pattern and are therefore referred to as “scaffolds
with a hexagonal array of interconnected pores (SHAIPs)”. SHAIPs contain both uniform pores
and interconnecting windows that can facilitate the exchange of biomacromolecules, ensure
homogeneous cell seeding, and promote cell migration. As a proof-of-concept demonstration, we
have created skeletal muscle patches with a thickness of approximately 150 μm using SHAIPs.
The myoblasts seeded in the scaffolds maintained high viability and were able to differentiate into
multi-nucleated myotubes. Moreover, neovasculature could efficiently develop into the patches
upon subcutaneous implantation in vivo.
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1. Introduction
The field of regenerative medicine has achieved tremendous progress in recent years with a
goal to restore functional tissues that are damaged by injuries or diseases. Although the
tissues to be engineered are thick (over several millimeters) in many cases, the regeneration
for certain injuries on the surfaces or interfaces requires the use of patch-like matrices with
thicknesses on the order of sub-millimeters, such as renal epithelium, epidermis and
myocardium. To realize the aim of healing these tissues from injuries, biomedical engineers
have long been seeking various solutions. One promising approach conceived by Okano and
co-workers is based on a technology known as the “cell sheet engineering” [1–6]. In this
technology, the cells are cultured in Petri dishes coated with a layer of thermoresponsive
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polymer, the poly(N-isopropylacrylamide) (pNIPAAm). Upon confluence, the cell sheets
can be spontaneously detached by reducing the temperature at which pNIPAAm becomes
hydrophilic and therefore inhibits cell adhesion. Due to its ease of operation, the cell sheet
technology has been adopted to generate cell patches for a variety of applications including
the regeneration of cornea [7], oral mucosal epithelium [3], and myocardium [8–12]. Despite
these huge successes, however, there are several issues associated with the cell sheet
technology. For example, the cell sheets are typically fragile and tend to crimple or fracture,
which makes them inconvenient for a surgical procedure. More importantly, because the cell
sheets are only composed of no more than a few layers of cells, the inadequate thickness
(around 10–30 μm) would potentially hinder their use in large wounds which are much more
common in humans than in small laboratory animals.
A number of alternative approaches have been developed that focus on the inclusion of
three-dimensional (3D) porous scaffolds [13, 14]. Scaffolds with interconnected pores can
function as physical supports for cells to attach and expand over a relatively large volume.
They are therefore well-suited as matrices for the creation of thick, cellularized patches to
repair large wounds. Nonetheless, the scaffolds used in most previous studies are fabricated
by stochastic porogen leaching methods. As a result, these scaffolds usually exhibit
completely random structures and large batch-to-batch variations, and the resulting poor
interconnectivity may potentially prevent the eventual formation of homogeneous tissues
[15]. To this end, the recently developed 3D porous scaffolds with an inverse opal structure
have come to our attention because of their long-range well-ordered structure, uniform pores
and interconnecting windows, as well as high reproducibility over different batches of
fabrication [16–21]. As demonstrated in our previous publications, the high
interconnectivity of these inverse opal scaffolds could facilitate the transport of
biomacromolecules and migration of cells [15]. The uniform pore size and structure also
made the scaffolds a well-defined system to study the effects of these parameters on cell and
tissue behaviors [15, 22]. In addition, the high reproducibility associated with the production
of inverse opal scaffolds is of particular importance when applying these scaffolds to clinical
applications, where the generation of on-shelf products with a consistent quality is a
prerequisite. To date, the inverse opal scaffolds have been extensively used in culturing
immune cells and embryonic stem cells [23, 24], neovascularization [22, 25], and bone [26,
27], cartilage [28, 29], liver [30], cardiac [31], and neural tissue engineering [32], among
others [33–36].
Here we report a novel category of porous scaffolds made from poly(D,L-lactic-co-glycolic)
acid (PLGA), which is essentially an extension from the inverse opal scaffolds. Different
from the inverse opal scaffolds with multiple layers of pores, we have fabricated scaffolds
composed of only a single layer of pores with a unique hexagonal arrangement. We call
them “scaffolds with a hexagonal array of interconnected pores (SHAIPs)”. Through the use
of SHAIPs, relatively thick cell patches (a few hundred micrometers) with homogeneous
tissue distribution could be fabricated thanks to the uniform pores and interconnecting
windows of the scaffolds. As a proof-of-concept demonstration, we created skeletal muscle
patches by seeding C2C12 murine myoblasts into SHAIPs, and then examined the
differentiation of the cells and neovascularization in the patches in vitro and in vivo,
respectively. When necessary, a few side-by-side comparisons were also made between the
patches obtained from SHAIPs and scaffold-free myoblast sheets.
2. Materials and methods
2.1. Chemicals and materials
Gelatin (Type A, from porcine skin), sorbitan monooleate (Span® 80), and toluene were
used to generate uniform gelatin microspheres. PLGA (lactide:glycolide = 75:25, Mw =
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66,000–107,000) and 1,4-dioxane were used to fabricate the scaffolds. All the chemicals and
materials were obtained from Sigma-Aldrich (St. Louis, MO) and used as-received unless
otherwise noted.
2.2. Preparation of monolayer inverse opal scaffolds
PLGA SHAIPs were fabricated by modifying our previously published procedures for
fabricating inverse opal scaffolds [15, 23, 27, 37–41]. Briefly, a methanol suspension of
gelatin microspheres was slowly dropped from the elevated end of a rectangular mold made
of polydimethylsiloxane (PDMS, Dow Corning, Midland, MI) positioned at a tilt angle of
about 15 degrees. The mold was then gently tapped to obtain a monolayer of hexagonally
packed gelatin microspheres. The mold containing the hexagonal array was sealed in a
Nalgene® jar filled with methanol and placed in an oven heated at 80 °C for 1 h to induce
necking between the adjacent gelatin microspheres. After cooling down to room
temperature, the lattice pellet was carefully harvested by a spatula, placed on a filter paper to
allow methanol to evaporate completely, and then infiltrated with a PLGA solution in 1,4-
dioxane (20 wt.%). After removing the excess PLGA solution on both sides of the structure
with a filter paper, the sample was frozen in a refrigerator (−20 °C) for 5 h, and lyophilized
overnight in a freeze-dryer (Labconco, Kansas City, MO). The pellet with freeze-dried
PLGA was immersed in ethanol for 2 min under mild vacuum to eliminate air bubbles
trapped inside and then transferred into a beaker containing 900 mL water. The sample was
heated at 43 °C for 3–4 h under gentle magnetic stirring to remove the gelatin lattice.
2.3 Culture of C2C12 myoblasts
C2C12 murine myoblasts were obtained from American Type Culture Collection (ATCC,
Manassas, VA). The cells were maintained in a Dulbecco’s modified Eagle medium
(DMEM, Invitrogen, Carlsbad, CA) supplemented with 10 vol.% heat-inactivated fetal
bovine serum (FBS, ATCC, Manassas, VA) and 1 vol.% penicillin-streptomycin (P/S,
Invitrogen) under 37 °C and 5% CO2. To produce cell sheets, we devised a simple method
without the need of any thermal-responsive coating. Briefly, the cells were seeded in the
wells of a 96-well plate at a density of 1 × 104 cells per well. Upon culture for a few days,
the myoblasts in each well could gradually form an intact cell sheet, which became easily
detachable from the bottom of the well simply using a pair of tweezers. For producing cell
patches, cells of approximately the same number were seeded into each scaffold using a
spinner flask (125 mL capacity, Corning, NY) at 65 rpm for 2 h. The cell-seeded scaffolds
were then transferred into the wells of a tissue-culture non-treated 12-well plate (1 scaffold
per well), and 1 mL of culture medium was added into each well. When necessary, the
differentiation of myoblasts was induced by culturing the cells in DMEM supplemented
with 2 vol.% horse serum (Invitrogen) and 1 vol.% P/S for 5–10 days.
2.4. Cell proliferation assay
Cell proliferation was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assays. The assay was carried out by adding 40 μL of MTT (Invitrogen)
solution in phosphate buffered saline (PBS, Invitrogen, 5 mg/mL) to each well and the
sample was then incubated at 37 °C for 3 h. Finally, the culture medium was withdrawn and
1 mL isopropanol was added to each well to completely dissolve the formazan crystals.
Absorbance was measured at 562 nm using a spectrophotometer (Infinite 200, TECAN,
Durham, NC).
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2.5. Characterization of cells, immunostainning, and histology
To visualize their proliferation, the cells were stained with calcein AM (Invitrogen, 2 μM in
culture medium at 37 °C for 30 min), washed with culture medium, and then observed under
an Olympus microscope equipped with Capture 2.90.1 (Olympus, Center Valley, PA).
Transverse sections were obtained by fixing the samples in a 2 vol.% glutaraldehyde
solution in PBS, followed by embedding in paraffin and sectioning at a thickness of 5 μm.
The samples were stained with hematoxylin and eosin and bright-field transmission optical
micrographs were taken using a Nanozoomer Digital Pathology (Hamamatsu, Bridgewater,
NJ).
Differentiated myoblasts were fixed in a 4 vol.% formaldehyde solution in PBS. Alexa-568
phalloidin (Invitrogen) was used to stain f-actin (1:100 dilution). Myotubes were stained
using mouse anti-myogenin primary antibody (Abcam, Cambridge, MA, 1:200 dilution) and
Alexa-488 goat anti-mouse secondary antibody (Invitrogen, 1:200 dilution). Nuclei were
counter-stained with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen). The staining results
were examined using a confocal laser scanning microscope (CLSM, LSM 510, Zeiss,
Thornwood, NY).
2.6. Animals and histology
All animal experiments were performed in accordance with protocols approved by the
Washington University Department of Comparative Medicine and the Animal Studies
Committee. Athymic Nude mice 4–5 weeks old were obtained from Harlan (Indianapolis,
IN) and housed under specific pathogen-free conditions in the animal facility at Washington
University in St. Louis. Scaffolds with a size of approximately 2 × 2 mm2 were implanted
subcutaneously into ears of the mice at one scaffold per ear per mouse [41]. At 4 weeks
post-implantation, all animals were euthanized using sodium pentobarbital (200 mg/kg, IP)
prior to explantation of the scaffolds. The ears of the mice were immediately collected, fixed
in a 4 vol.% formaldehyde solution in PBS for 24 h and then dehydrated and embedded in
paraffin wax. Serial sections (5 μm in thickness) were collected on glass slides and stained
with hematoxylin and eosin. The slides were imaged using a Nanozoomer Digital Pathology
slide scanner. Quantifications of both the blood vessel density and the blood vessel-to-tissue
area-ratio within the scaffold areas were obtained using the ImageJ software (National
Institute of Health, NIH, Bethesda, MD). Blood vessel density was determined by
normalizing the number of blood vessels of a section to the area of the section, and was
expressed as number per unite area (#/mm2). Blood vessel-to-tissue area ratio was defined as
the percentage (%) of total area of all the blood vessels in a tissue/scaffold section to the
total area of the section.
2.7. Statistical Analysis
Quantitative data were obtained by measuring vessels from at least 5 random sections for
each sample (n = 3). Results were reported as mean ± standard deviation.
2.8. Optical Resolution Photoacoustic microscopy (OR-PAM)
The OR-PAM system used in this study had a lateral resolution of approximately 5 μm, an
axial resolution of approximately 15 μm and a penetration depth of approximately 1.2 mm in
soft tissues [42, 43]. A tunable dye laser (CBR-D, Sirah, Kaarst, Germany) pumped by a
Nd:YLF laser (INNOSAB, 523 nm, Edgewave, Würselen, Germany) was used as the
excitation source. The short pulses (5 ns) from the dye laser were focused by a microscope
objective (4×, NA = 0.1, Olympus America, Center Valley, PA) into the surface of the
sample. The photoacoustic signals were detected by a spherically focused ultrasonic
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transducer (V214-BC-RM, central frequency: 50 MHz, Olympus-NDT, Waltham, MA),
which was placed confocally with the objective. An ultrasound/light splitter, composed of a
thin layer of silicone oil sandwiched between a right-angle prism and a rhomboid prism, was
used for the co-axial alignment of the optical and acoustic beams. A plano-convex lens
attached onto the top of the splitter corrected the refraction of the prisms. Ultrasound gel
was used as the matching medium for acoustic propagation. A motion controller provided
trigger signals for laser firing, data acquisition, and raster scanning.
2.9. Scanning electron microscopy (SEM)
SEM (Nova NanoSEM 2300, FEI, Hillsboro, OR) was used to characterize the scaffolds.
Prior to imaging, the samples were sputter-coated with gold for 60 s. Images were taken at
an accelerating voltage of 5 kV.
3. Results and Discussion
3.1. PLGA SHAIPs and C2C12 myoblasts culture in the scaffolds
The inverse opal scaffold is a 3D porous structure fabricated by templating against a cubic
close packed lattice of microspheres with uniform sizes [15, 23, 27, 37–41]. When the lattice
is only comprised of a single layer of microspheres, the resulting scaffold becomes what we
refer to as the SHAIP. Fig. 1A shows a schematic of the typical process for the fabrication of
a SHAIP. Firstly, the uniform microspheres of gelatin are packed into a single-layer-lattice,
followed by thermal annealing to induce necking between adjacent microspheres. Secondly,
a solution containing the scaffolding material is infiltrated into the void space of the lattice
and freeze-dried. Finally, the microspheres are selectively removed, leaving behind only the
porous scaffold. It is important to note a few unique features of SHAIPs: i) The pore size
(the size of the spherical pores) is uniform, which is inherited from the monodispersity of
the microspheres used as the template (Fig. 1B). The pore size (and thus the corresponding
thickness) of a scaffold is readily adjustable within a wide range of approximately 50–1000
μm depending on the size of the templating microspheres. ii) Each pore has six windows in
uniform size connecting to adjacent pores (Fig. 1C). The size of these windows is typically
about 15–20% of the pore size and can be precisely adjusted by controlling the conditions
under which the gelatin microspheres are annealed [40]. The uniform pores and windows
represent a unique feature of SHAIPs since they can facilitate the diffusion of nutrients and
wastes, ensure the homogenous distribution of cells at the time of seeding, and promote the
migration of cells during the culture [15]. iii) There are two openings on the two sides of
each pore, which are defined as the surface pores (Fig. 1C) [25, 40]. Typically, the excess
solution on both surfaces of a templating lattice is removed by wiping with a filter paper.
The solution remaining in the meniscus among adjacent microspheres then solidifies after
freeze-drying to form circular pores with a size slightly smaller than the diameter of the
templating microspheres. These large and uniform surface pores can greatly facilitate the
seeding of cells into the scaffold and potentially also induce the formation of a better tissue-
scaffold interface when implanted in vivo. Importantly, the size of these surface pores can be
finely tuned as well, depending on the properties of the solution containing the scaffolding
material [40].
In this work, we fabricated PLGA SHAIPs by templating against gelatin microspheres of
200 μm in diameter. Fig. 2, A and B, shows SEM images of a single-layered gelatin lattice
after thermal annealing and a PLGA scaffold, respectively, at tilt angles. The gelatin
microspheres were annealed at 75–80 °C for 1 h, resulting in a window size of
approximately 40 μm (20% of the pore size). We used a 20 wt.% PLGA solution in 1,4-
dioxane as the infiltration solution, so that the size of the surface pores was 60–70% of the
pore size, i.e., the scaffolds had a surface pore size of approximately 130 μm. The ordered
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arrangement of the gelatin microspheres and the uniform pore size of the scaffold could be
more clearly observed in optical micrographs (Fig. 2, C and D). As shown in Fig. 2, E and F,
both the monolayer gelatin lattice and the PLGA SHAIP were robust enough to be handled
with a pair of tweezers. The overall flexibility of the SHAIP also potentially allows the
scaffold to conform to the shape of an injury site and adhere well to that surface, thus
expediting the healing process.
3.2. Proliferation of myoblasts in vitro
C2C12 mouse myoblasts were seeded into the porous scaffolds using a spinner flask and
maintained in a proliferation medium. The cells were visualized using a fluorescence
microscope after staining the cytoplasm with calcein AM. As shown in Fig. 3A, the cells
were distributed homogeneously across the entire region of the scaffold at day 1 post-
seeding and they mainly stretched along the polymer backbones. By day 7, the cells could
occupy most of the void spaces of the pores (Fig. 3B).
We then quantified the proliferation of myoblasts in PLGA SHAIPs (with dimensions of 4 ×
8 × 0.15 mm3). As shown in Fig. 3C, the cells proliferated fast at the initial stage from days
1–7 to reach confluence in the scaffolds. The proliferation rates slowed down remarkably
after 7 days of culture. It is further noted that, the cells in the scaffold could still maintain
their viability at a reasonable level after they had reached confluence. This observation
should be attributed to the relatively small thickness of these scaffolds (about 150 μm) that
is close to the diffusion limits of biomolecules, unlike their thicker (>1 mm) counterparts
where the cells in the bulk of the scaffolds tend to undergo apoptosis or necrosis during
prolonged culture in vitro due to the insufficient supply of oxygen and nutrients [27].
To examine 3D cell distribution, we next obtained sections along the transverse plane of the
SHAIP constructs as well as the cell sheets. Fig. 4, A and B, shows representative
micrographs of hematoxylin and eosin stained sections. While the thickness of a cell sheet
was largely confined to about 20–30 μm (Fig. 4A), cell patches fabricated using the SHAIP
could support the distribution of cells throughout the entire thickness (about 150 μm) of the
scaffold (Fig. 4B). In addition, because of the very thin structure of the cell sheet, it tended
to fold significantly when released from the bottom of a culture well (Fig. 4C), which
potentially renders its handling relatively inconvenient during a surgery. The cell sheet
technology is also unlikely to be used for deep/large wounds that occur more commonly in
large animals including humans unless stacking of multiple layers of cell sheets is performed
[44]. The stacking, however, may complicate their handling in a surgical procedure. By
contrast, a cellularized SHAIP was free-standing, and could be easily picked up with a pair
of tweezers (Fig. 4D), thus facilitating their use in a surgery. The greater thickness of these
patches based on SHAIPs is also advantageous when they are used for repairing large and
deep wounds on surfaces or interfaces.
3.3. Differentiation of myoblasts in vitro
We then investigated the ability of myoblasts to differentiate in PLGA SHAIPs, since the
functional recovery of skeletal muscles is highly dependent on the efficient formation of
myotubes [45]. After 3 days of culture in a proliferation medium, SHAIPs populated by
myoblasts were transferred into a differentiation medium for 10 additional days and then
subjected to immunostaining. Fig. 5, A–D, shows a transmission optical micrograph of the
cell-scaffold construct, and fluorescence micrographs of stainings for f-actin, myogenin, and
nuclei of the cells, respectively. A superimposed image is indicated in Fig. 5E. It could be
observed from the images that, most of the cells became myogenin-positive, confirming the
differentiation of myoblasts. Interestingly, unlike the uniform distribution of cells when they
were cultured in the proliferation medium (Fig. 3B), the differentiated myoblasts formed
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individual cell bodies in the pores (each cell body per pore), and any of the two adjacent cell
bodies were connected by elongated, aligned myotubes through the interconnecting window
between the two pores. Similar organization of the cells was also described by Lin and co-
workers where they induced the differentiation of myoblasts in gelatin-based inverse opal
scaffolds [21], indicating that the behaviors of these cells were more dependent on the
structure rather than the material of a scaffold. From an enlarged view of the superimposed
image (Fig. 5F), the presence of multi-nucleated myotubes that connected the adjacent cell
bodies were clearly visible.
3.4. In vivo evaluation
Skeletal muscles are highly vascularized in order to provide them with sufficient supplies of
oxygen and nutrients for their strong metabolic activity [46]. We therefore examined the
capability of the myoblast patches to induce neovascularization. After culturing in a
differentiation medium, the patches based on SHAIPs were implanted subcutaneously in the
ears of nude mice (1 scaffold per ear per mouse) [41]. The scaffolds were positioned on top
of the central cartilage but below the dermis where the majority of blood vessels resided,
such that the vessels could only invade into the scaffolds from the top surfaces.
Neovascularization was examined non-invasively using OR-PAM at 2 weeks post
implantation [41, 47, 48]. Fig. 6A, top and bottom panels, shows coronal and sagittal
maximum amplitude projection (MAP) images, respectively, of neovasculature developed in
a hexagonal array scaffold patch. The boundary of the patch is indicated by a white dotted
square in each image. It is obvious that the neovasculature could develop uniformly
throughout the entire volume of the patch thanks to the high interconnectivity of the
scaffold.
The formation of muscles and blood vessels was further examined via histology at 4 weeks
post implantation. Fig. 6B shows a bright-field optical micrograph of hematoxylin and eosin
stained vertical sections of the implant from a SHAIP patch. Partially aligned muscle
bundles with a uniform thickness encompassing a few blood vessels (indicated by yellow
arrowheads) developed upon implantation, possibly originated from the aligned myotubes
connecting the adjacent cell bodies in the patch. Quantitative analyses revealed that, the
patches induced the formation of a blood vessel density of 86.08 ± 13.55/mm2 and a blood
vessel-to-tissue area ratio of 3.03 ± 0.48%. Comparing with our previous study where
inverse opal scaffolds with a comparable pore size were used, such ratio for the SHAIPs was
remarkably larger than that in the bulk but similar to that close to the surface of the inverse
opal scaffolds [25]. This result is reasonable because a SHAIP is in essence the top layer of
an inverse opal scaffold. As a result, the blood vessels could easily penetrate into the pores
from tissues on the top due to the large surface pore size of the SHAIP. In addition, the
paracrine effect of C2C12 cells grown in the scaffold might also contribute to its high
vascularity, because it is known that C2C12 cells could secret a number of angiogenic
growth factors (e.g., vascular endothelial growth factor) under certain stimulation [49–51].
4. Conclusion
In summary, we have successfully fabricated PLGA scaffolds consisted of a single layer of
spherical pores with a hexagonal arrangement, the so-called “scaffolds with a hexagonal
array of interconnected pores (SHAIPs)”. These scaffolds had a uniform pore size, high
interconnectivity between the pores, as well as large openings on both surfaces. We expect
that SHAIPs are likely to find widespread applications in fabricating cellularized patches for
healing large wounds on surfaces or interfaces.
As a proof-of-concept demonstration, we could obtain skeletal myoblast patches with a
thickness of about 150 μm by using SHAIPs. Myoblasts cultured in SHAIPs were capable of
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differentiating into elongated myotubes in vitro and induce extensive neovascularization
when implanted in vivo. Of course, additional work still needs to be conducted before this
technique can be further extended to clinical studies. For example, although C2C12 is a
well-established myoblast cell line, it does not racapitulate myogenesis as precisely as
primary myoblasts [52–55]. Therefore, future investigations should include primary cultures
derived directly from satellite cells. In addition, biophysical analyses (e.g., force
measurement) are needed to assess the functional recovery of muscles in vivo.
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• We have fabricated scaffolds with a hexagonal array of interconnected pores
(SHAIPs).
• SHAIPs have a well-ordered structure, uniform pores, and high
interconnectivity.
• C2C12 myoblast patches as thick as 150 μm have been produced using SHAIPs.
• SHAIPs support in vitro proliferation and differentiation of myoblasts.
• SHAIPs induce extensive neovascularization upon implantation in vivo.
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Figure 1.
A) Schematic illustration of the procedure for fabrication of a SHAIP (side view): i) uniform
microparticles are assembled into a close-packed monolayer lattice; ii) the scaffolding
material is infiltrated into the voids and the extra solution on both surfaces is removed with a
filter paper followed by freeze-drying; iii) the lattice is selectively removed, leaving behind
the scaffold. B) Schematic of the SHAIP, and C) an enlarged view of a pore indicating the
high interconnectivity (six uniform windows connecting adjacent pores) of the scaffold.
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Figure 2.
A, B) SEM images showing (A) a monolayer of gelatin microspheres after thermal fusion
and (B) a PLGA SHAIP after removal of the gelatin lattice, both at tilt angles. C, D)
Transmission bright-field optical micrographs showing the top view of (C) a lattice of the
gelatin microspheres and (D) a PLGA SHAIP. E, F) Reflection bright-field optical
micrographs showing (E) a free-standing lattice of the gelatin microspheres after thermal
fusion and (F) a free-standing PLGA SHAIP held by a pair of tweezers.
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Figure 3.
A, B) Fluorescence micrographs showing C2C12 myoblasts grown in PLGA SHAIPs at
days 1 and 7, respectively. The cells were stained with calcein AM for cytoplasm. C)
Proliferation profile of C2C12 myoblasts cultured in PLGA SHAIPs, as determined by the
MTT assay.
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Figure 4.
A, B) Transmission bright-field optical micrographs showing hematoxylin and eosin stained
transverse sections of (A) a myoblast cell sheet and (B) myoblasts grown in a PLGA
SHAIP. C, D) Fluorescence micrographs showing (C) a detached myoblast cell sheet and
(D) a free-standing myoblast patch in a PLGA SHAIP; the cells were stained with calcein
AM for cytoplasm.
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Figure 5.
C2C12 myoblasts cultured in a PLGA SHAIP in a differentiation medium for 10 days. A) A
transmission bright-field optical micrograph showing the cells grown in the scaffold. B–D)
CLSM images showing (B) f-actin, (C) myogenin, which is a marker for differentiated
myoblasts, and (D) nuclei. E) Superimposed image of (B–D). F) An enlarged view of the
superimposed image showing multinucleated myotubes connecting the cell bodies in
adjacent pores.
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Figure 6.
A) Top panel: a coronal PAM MAP image at the depth of the implant (optical section
thickness: approximately 200 μm) showing neovascularization within a myoblast patch
based on PLGA SHAIP at 2 weeks post implantation; Bottom panel: corresponding sagittal
PAM MAP image from the central region of the patch (optical section thickness:
approximately 500 μm). The white dotted square in each image denotes the rough boundary
of the patch. MAP stands for “Maximum Amplitude Projection”. B) A bright-field optical
micrograph showing hematoxylin and eosin stained transverse section of the implant at 4
weeks post implantation. Yellow arrowheads indicate blood vessels.
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